Shenghong Group launches biological PDO and PTT program

On May 5, 2013, a ground-breaking ceremony of a 20,000t/a biological PDO and 50,000t/a PTT program was held by Shenghong Group Co., Ltd. (Shenghong Group). This program is owned by Suzhou Suzhen Biological Engineer Co., Ltd., a subsidiary of Shenghong Group. The launch of this program enables Shenghong Group to have a whole production chain from biological raw material, PTT polyester to PTT spinning and fabric printing & dyeing, according to CCM’s latest issue of Biomaterials China News 1305.

 

The newly-launched biological PDO and PTT program is just the first phase of Shenghong Group's whole PDO and PTT program, and is planned to be put into production at the end of 2013, while the second phase with capacities of 40,000t/a PDO and 100,000t/a PTT is expected to enter operation in 2015. By cooperating with Tsinghua University, PDO will be produced by biological method, fermented from glycerol—a by-product of biodiesel, which is different from the raw material of general biological PDO, such as DuPont's PDO.

This program will be perfection and expansion of Shenghong Group’s current PTT business.

 

PTT fiber is famous as a kind of "memory fiber", but the supply shortage of its core raw material—PDO hasseriously restricted the development of the PTT industry. In June 2011, Shenghong Group’s first domestic PTT production line with a capacity of 30,000t/a entered trial production, allowing the company to become the third one who mastered the core technology of PTT in the world, only after DuPont and Shell. However, the company does not have its own PDO production line, and most of PDO it needed is bought from Shell. According to Mr. Bian, the company’s chief engineer, the outsourced BDO cannot meet the company's production needs. Another industry insider, Mr. Han, also revealed that though Shenghong Group has a large PTT production capacity, its PTT output is far smaller than its capacity due to the supply shortage of PDO.

 

In the future, after the company’s new program is finished, the raw material bottleneck will be solved, and the newly-constructed PTT production line and the company’s integrated production chain will greatly help the company to win more market share.

Along with the technology innovation and the great development of the biodiesel industry, more domestic enterprises will enter the PDO industry, and China may become one of the largest PDO producers in the future.

 

In addition to Shenghong Group, Zhangjiagang Glory Biomaterial Co., Ltd. (Glory Biomaterial) also launched a biological PDO program, and the first phase with a capacity of 20,000t/a PDO has entered pilot production in Jan. 2013. Similar to Shenghong Group, Glory Biomaterial also produced PDO from glycerol by cooperating with another university—East China University of Science and Technology.

Table of Contents of Biomaterials China News 1305:

China's PVA market deteriorates continuously in 2012

Shenghong Group launches biological PDO and PTT program

The profit of Global Bio-Chem's polyol chemicals segment decreases sharply in 2012

Rainbow Fine Chemical has a bad performance in 2012

Lenzing constructs a jumbo lyocell fiber production line

China makes new progress in hydrolysis stabilizer development

Development of succinic acid commercial production technology in China

Corn price decreases slowly from Feb. 2013

China's PLA foreign trade improves in March 2013

China's import volume of fresh and dry cassava increases in March 2013

China's import volume and price of castor oil and its derivatives increase in March 2013

Rongsheng Petro Chemical's PTT fiber program delayed

Sulzer undertakes a contract for a PLA production plant in Asia

Coca-Cola launches plant-based bottle in China

Toray succeeds in production of bio-based PBT

Polythene UK successfully launches bio-based polyethylene

Biomaterials China News, with 12 to 14 topics in one issue, published by CCM on 8^th every month, will bring you the latest information on the market dynamics, company dynamics, new biomaterials products, new biomaterials technology development, new legislations as well as policies and raw material supply dynamics, which are shaping the significant market intelligence of the industry.

About CCM

CCM is dedicated to market research in China, Asia-Pacific Rim and global market. With a staff of more than 150 dedicated highly-educated professionals, CCM offers Market Data, Analysis, Reports, Newsletters, Buyer-Trader Information, Import/Export Analysis, and consultancy service. 

For more information, please visit http://www.cnchemicals.com.

Guangzhou CCM Information Science & Technology Co., Ltd.
17th Floor, Huihua Commercial & Trade Mansion, No.80 Xianlie Zhong Road, Guangzhou 510070, China

Tel: 86-20-37616606

Email: econtact@cnchemicals.com

Zhangjiagang Huamei to launch PDO products in April 2012

Zhangjiagang Huamei Biomaterial Co., Ltd. (Zhangjiagang Huamei) plans to launch its 1,3-propanediol (PDO) products in April 2012, revealed by CCM International’s first issue of Biomaterials China News.

Zhangjiagang Huamei is a new company established by Zhangjiagang Meijingrong Chemical Industry Co., Ltd. (Zhangjiagang Meijingrong) and SB China Venture Capital Limited (SBCVC) that cooperated with each other. They invested about USD24 million to build a PDO production line with total capacity of 65,000t/a. On September 8, 2011, Zhangjiagang Huamei started the construction of the first phase of the PDO production line with capacity of 13,000t/a in Changjiang River Chemical Industrial Park. It is estimated that PDO products will be launched in April 2012, revealed by a staff from Zhangjiagang Meijingrong. Meanwhile, he claims that the company will also launch its PTT products, PDO downstream products, when it finishes the current cooperation contract with Dupont.

Mr. Han, general manager of Zhangjiagang Meijingrong, is proud that the new PDO production line will increase the annual sales revenue to nearly USD173 million when the whole construction is finished. Besides, the annual return of Zhangjiagang Meijingrong will reach more than USD47.25 million after the formation of the PTT upstream and downstream industry in Zhangjiagang Meijingrong.

It is predicted that Zhangjiagang Huamei will become the second biggest PDO producer around the world when it reaches the total capacity. Actually, at present, there are only three major companies producing PDO products around the world, Degussa Co., Ltd. (Degussa), Shell and Dupont. Although some domestic manufacturers have the capability to produce PDO products, their capacities are lower than ten thousand tonnes per year separately. Mr. Han believes that the PDO production industry will be prosperous as the PTT capacity become larger and larger in future.

Want to find out more about the influence that worldwide economic downturn makes on China’s PTT industry, please check Biomaterials China News. If you need free sample of this newsletter, please contact us at econtact@cnchemicals.com.

Specific News of Biomaterials China News include:

-China to accelerate development of biomaterials

-Overview of development of milk protein fiber in China

-Worldwide economic downturn affects PTT sales in China

-PHA manufacturers to benefit from the ban on plastic in Europe and in America

-Chitosan fiber still has a long distance to the industrial production

-Suzhou HiPro to expand its bio-polyamide capacity

-Wanwei Updated High-tech expands PVA capacity

-Nanyang Zhongju Tianguan to expand its PPC resin capacity

-Zhejiang Hisun to expand its PLA capacity in 2013

-Changchun Dacheng expands its corn-based monoethylene glycol capacity

-RSPC accelerates its expansion of PTT upstream production lines

-Zhangjiagang Huamei to launch PDO products in April 2012

… …

About CCM

CCM is dedicated to market research in China, Asia-Pacific Rim and global market. With a staff of more than 150 dedicated highly-educated professionals. CCM offers Market Data, Analysis, Reports, Newsletters, Buyer-Trader Information, Import/Export Analysis all through its new proprietary product ValoTracer.

For more information, please visit http://www.cnchemicals.com.

CCM International Ltd.
Guangzhou CCM Information Science & Technology Co., Ltd.
17th Floor, Huihua Commercial & Trade Mansion, No.80 Xianlie Zhong Road, Guangzhou 510070, China

Tel: 86-20-37616606

Email: econtact@cnchemicals.com

Source: http://www.cnchemicals.com/PressRoom/PressRoomDetail_c_928.html

RSPC Boosts Expansion of PTT Upstream Production Lines

CCM International has published the November Issue of Industrial Biotechnology China News recently. The top story is that Rongsheng Petrochemical Co., Ltd. (RSPC) accelerates its expansion of polytrimethylene-tereph-thalate (PTT) upstream production lines in 2011-2012, including three parts: Pure Terephthalic Acid (PTA) capacity expansion, paraxylene (PX) and mixed aromatic (MX) production lines' construction respectively.

Ms. Quan, the board secretary of RSPC, Yisheng Dahua Petrochemical Co., Ltd. (Yisheng Dahua), RSPC's subsidiary company, points out that RSPC will expand its PTA capacity from 1,200,000t/a to 1,750,000t/a at the end of 2011. And Zhejiang Yisheng Petrochemical Co., Ltd. (Zhejiang Yisheng), RSPC's another subsidiary company,  accelerates its third phase of PTA production line construction with capacity of 1,500,000t/a.

As of construction of PX production line and MX production line, Ms. Quan claims that the PX production line with capacity of 700,000t/a and the MX production line with capacity of 900,000t/a are being planned.

MX production line is prepared for PX production because MX is the raw material of PX. Ms. Quan emphasizes that the future strategy of RSPC is to develop PTA's upriver and downriver industry, especially PX production line, so as to guarantee the raw material supply of PTA.

Actually, RSPC's PX production line plays an important role in the construction of PTT upstream production lines. RSPC constructs the production line of MX in order to guarantee raw material supply of PX. It can be predicted that RSPC can produce PX itself in future, meanwhile, the fact of introducing the raw material of PX from other companies will become the past.

For detail information about RSPC’s PTT production project, please check Industrial Biotechnology China News 1111. Followings are major headline news:

-Wuhan Kaidi will launch four biomass power plants in the next two months in 2011.

-Shandong Longlive hadn't received the approval of becoming a national designated producer of fuel ethanol by the end of October 2011.

-Chengdu Jiujiang Environmental Protection Power Plant is launched in Mid-October 2011.

-Beijing Qihuamei launches the heat-resistant SOD tablet in October 2011.

-The sewage treatment policy produces business opportunities to Origin Water.

-Kingdomway launches IPO on October 28, 2011.

-In September 2011, China's import volume of butanol was up by 13.35% compared with that in August 2011.

-Novozymes plans to launch its pharmaceutical grade HA  for external sales in China in 2012.

-Wanwei Updated High-tech will expand its PVA capacity to 250,000t/a at the beginning of 2012.

-RSPC accelerates its expansion of PTT upstream production lines.

-China's PLA import volume increased by more than 50% while price of PLA export sharply reduced in September 2011.

-Nanyang Zhongju Tianguan plans to expand its PPC capacity to 31,000t/a in 2012 from 6,000t/a now.

About CCM

CCM is dedicated to market research in China, Asia-Pacific Rim and global market. With a staff of more than 150 dedicated highly-educated professionals. CCM offers Market Data, Analysis, Reports, Newsletters, Buyer-Trader Information, Import/Export Analysis all through its new proprietary product ValoTracer.

For more information, please visit http://www.cnchemicals.com.

CCM International Ltd.
Guangzhou CCM Information Science & Technology Co., Ltd.
17th Floor, Huihua Commercial & Trade Mansion, No.80 Xianlie Zhong Road, Guangzhou 510070, China

Tel: 86-20-37616606

Email: econtact@cnchemicals.com

Source: http://www.cnchemicals.com/PressRoom/PressRoomDetail_c_828.html

CCM International’s First Issue Biomaterials China News Coming Soon

The first issue of CCM’s Biomaterials China News is estimated to be published in December 2011. Covering columns of market dynamics, price update, company dynamics, import & export analysis, raw material supply and special report, this newsletter will present you the most comprehensive information of China’s biomaterial market.

Why to subscribe?

Having developed rapidly in China in recent years, biomaterials are expected to have a promising market in the future. Some types of biomaterials have achieved great process, such as Poly (lactic acid) (PLA), Polyhydroxyalkanoate (PHA) and Poly (butanediol succinate) (PBS). Domestic manufacturers aim to expand their capacities or increase investment in biomaterials.

Although the market is huge, it is not mature in China. It’s necessary to learn the whole market so as to make wise decisions. Keeping abreast of the dynamics of China’s biomaterials industry is very important for the biomaterial companies. CCM International’s Biomaterials China News will meet all your needs. The newsletter will let you obtain the useful information and make you discover the business opportunities in this industry.

What categories will be reported?

Biomaterials refers to those use renewable materials as raw materials. The latest update and insightful analysis of raw materials, together with biomaterials will be shared in this newsletter.

(1) Raw Material

Corn, potato and cassava, etc.

(2) Biomaterials

-Natural bio-based materials: starch (PSM), cellulose, protein, chitin and lignin;

-Microbial synthetic materials: microbial polysaccharides; microbial polyesters (PHA products);

-Chemical synthesis of bio-based materials: polylactic acid (PLA); poly butylene succinate (PBS); poly propylene carbonate (PPC); polyvinyl alcohol (PVA); polyethylene terephthalate (PTT); polyethylene terephthalate (PET); poly amino acids; poly phosphazene; poly anhydride.

-Bio-nylon: polyamide (PA, raw materials from castor oil, etc.); long-chain dicarboxylic acid (LDA)

If you are interested in CCM’s Biomaterials China News, please feel free to contact us at econtact@cnchemicals.com.

(Guangzhou China, November 18, 2011)

About CCM

CCM is dedicated to market research in China, Asia-Pacific Rim and global market. With a staff of more than 150 dedicated highly-educated professionals. CCM offers Market Data, Analysis, Reports, Newsletters, Buyer-Trader Information, Import/Export Analysis all through its new proprietary product ValoTracer.

For more information, please visit http://www.cnchemicals.com.

CCM International Ltd.
Guangzhou CCM Information Science & Technology Co., Ltd.
17th Floor, Huihua Commercial & Trade Mansion, No.80 Xianlie Zhong Road, Guangzhou 510070, China

Tel: 86-20-37616606

Email: econtact@cnchemicals.com

Source: http://www.cnchemicals.com/PressRoom/PressRoomDetail_c_837.html

RSPC Accelerates Its Expansion of PTT Upstream Production Lines

Rongsheng Petrochemical Co., Ltd. (RSPC) accelerates its expansion of polytrimethylene-tereph-thalate (PTT) upstream production lines in 2011-2012, including three parts: Pure Terephthalic Acid (PTA) capacity expansion, paraxylene (PX) and mixed aromatic (MX) production lines' construction respectively, revealing in CCM’s November Issue of Industrial Biotechnology China News.

According to Ms. Quan, the board secretary of RSPC, Yisheng Dahua Petrochemical Co., Ltd. (Yisheng Dahua), RSPC's subsidiary company,  will expand its PTA capacity to 1,750,000t/a at the end of 2011 from 1,200,000t/a. Recently, RSPC's share holding ratio reaches 56%, which means that RSPC's rights and interests of PTA capacity in Yisheng Dahua will increase to 1,092,000t/a from 672,000t/a.

Moreover, Zhejiang Yisheng Petrochemical Co., Ltd. (Zhejiang Yisheng), RSPC's another subsidiary company,  accelerates its third phase of PTA production line construction with capacity of 1,500,000t/a. Thanks to RSPC's share holding ratio of 30% of Zhejiang Yisheng, RSPC will have PTA's capacity expansion to 768,000t/a in November 2011 from 318,000t/a recently. More importantly, in order to raise its own PTA capacity, RSPC plans to take a further step to increase Zhejiang Yisheng's capital.

In addition to PTA capacity expansion, RSPC is trying its best to involve in the PTA's upstream production: construction of PX production line and MX production line. Ms. Quan claims that the PX production line with capacity of 700,000t/a and the MX production line with capacity of 900,000t/a are being planned. The MX production line now is under the basic design process. Although the PX production line is under the pre-planning stage, Ms. Quan is confident with the construction progress of the PX production line. She discloses the specific arrangement of the PX production line will be written in the future announcement.

She explains that these two different production lines will be launched in the near future. MX production line is prepared for PX production because MX is the raw material of PX. On the other hand, Ms. Quan emphasizes that the future strategy of RSPC is to develop PTA's upriver and downriver industry, especially PX production line, so as to guarantee the raw material supply of PTA. Furthermore, its PTT production line with capacity of 90,000t/a is now under construction, and it will be finished in June 2012, ahead of the former schedule which plans to launch the PTT production line in 2013.

Actually, RSPC's PX production line plays an important role in the construction of PTT upstream production lines. Its preparation of PX production line illustrates its purpose. RSPC constructs the production line of MX in order to guarantee raw material supply of PX. It can be predicted that RSPC can produce PX itself in future, meanwhile, the fact of introducing the raw material of PX from other companies will become the past.

Mr. Zhang, the engineer of Sinopec Beijing Research Institute of Chemical, acknowledges that PX capacity expansion in China can fulfill the companies' PX demand in future. He adds that in the past 10 years, although the capacity of PX has doubled, the demand of PX has increased at the same rate. RSPC's PX expansion can not only reduce its PTA production cost efficiently, but it can also get rid of dependence on other PX manufacturers.

Mr. Guo estimates that PX's capacity in China will reach 18.2 million tonnes per year in 2020. Meanwhile, PTA's output will reach 31 million tonnes in 2020. Mr. Guo is the director of China International Engineering Consulting Corporation petrochemical petrochemical, chemical textile Development.

As an insider of Sinopec Group reveals, the consumption of PX was more than 8 million tonnes in 2009. However, the output of PX in China was just 4.8 million tonnes. Recently, Sinopec Group, China National Petroleum Corporation and China National Offshore Oil Corporation occupy 70% of China's PX capacity.

But RSPC's PX production line construction has to face some difficulty. On September 26, 2011, due to the security incident of Dalian Fujia Petrochemical Co., Ltd. (Dalian Fujia), whose raw material of PX leakage damaged Dalian's environment, the Chinese government published the the emergency notification of strengthening the PX (paraxylene) and other sensitive products, safety and environmental protection work, so as to raise the entrance standard of PX industry.

Many PX producers are concerning about the new policy, and it is no exception to RSPC. Although the new policy makes RSPC worry about its new PX production line construction in future, Ms. Quan promises that the company will follow the new policy to build the PX production line.

Source: Industrial Biotechnology China News 1111

http://www.cnchemicals.com/Newsletter/NewsletterDetail_21.html

Main content of  Industrial Biotechnology China News 1111:

Wuhan Kaidi's four biomass power plants to launch

Shandong Longlive waiting for the national designated producer's permission of fuel ethanol

Chengdu Jiujiang Environmental Protection Power Plant launched in Mid October 2011

Beijing Qihuamei launches the heat-resistant SOD tablet in October 2011

Sewage treatment policy produces business opportunities to Origin Water

Kingdomway launches IPO on October 28, 2011

Trade analysis of butanol in China

Novozymes to launch pharmaceutical grade HA product for external sales

Wanwei Updated High-tech expanding PVA capacity

RSPC accelerates its expansion of PTT upstream production lines

Trade analysis of PLA in China 

Nanyang Zhongju Tianguan to expand its PPC resin capacity

Industrial Biotechnology China News, a monthly publication issued by CCM International on 8th of every month, focuses on biofuels, bio-products, bio-based chemicals, bio-materials and industrial biotechnology applications, offers latest investment hotspots, new technology & product, company & market dynamics, and government regulations, aiming to facilitate your insight into China's industrial biotechnology.

About CCM

CCM is dedicated to market research in China, Asia-Pacific Rim and global market. With a staff of more than 150 dedicated highly-educated professionals. CCM offers Market Data, Analysis, Reports, Newsletters, Buyer-Trader Information, Import/Export Analysis all through its new proprietary product ValoTracer.

For more information, please visit http://www.cnchemicals.com.

CCM International Ltd.
Guangzhou CCM Information Science & Technology Co., Ltd.
17th Floor, Huihua Commercial & Trade Mansion, No.80 Xianlie Zhong Road, Guangzhou 510070, China

Tel: 86-20-37616606

Email: econtact@cnchemicals.com

Source: http://www.cnchemicals.com/PressRoom/PressRoomDetail_w_806.html